Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Discovering and targeting vulnerabilities in invasive brain cancer using ROBO1 CAR T cells

Despite standard treatment efforts, patients with glioblastoma (GBM), an aggressive form of brain cancer, inevitably succumb to recurrent disease. Integrative genomic analyses reveal that tumor cells hijack normal neurodevelopmental pathways to promote GBM growth and invasion. To target this pathway, we engineer a CAR T cell therapy that blocks the growth of GBM and other invasive brain cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Blocking glioblastoma growth and invasion by targeting the PTP4A–ROBO1 signaling axis.

References

  1. Brown, C. E. et al. Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat. Med. 30, 1001–1012 (2024). This paper reports clinical trial results for IL-13Rα2-targeting CAR T cells in recurrent GBM.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bagley, S. J. et al. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results. Nat. Med. 30, 1320–1329 (2024). This paper reports clinical trial results for CAR T cells targeting EGFR and IL-13Rα2 in recurrent GBM.

    Article  CAS  PubMed  Google Scholar 

  3. Choi, B. D. et al. Intraventricular CARv3-TEAM-E T cells in recurrent glioblastoma. N. Engl. J. Med. 390, 1290–1298 (2024). This paper reports clinical trial results for a modified CAR T cell modality targeting EGFR in recurrent GBM.

    Article  CAS  PubMed  Google Scholar 

  4. Urwyler, O. et al. Branch-restricted localization of phosphatase Prl-1 specifies axonal synaptogenesis domains. Science 364, eaau9952 (2019). This paper reports the role of Ptp4a1 (also known as Prl-1) in Drosophila axonal guidance processes.

    Article  CAS  PubMed  Google Scholar 

  5. Huang-Hobbs, E. et al. Remote neuronal activity drives glioma progression through SEMA4F. Nature 619, 844–850 (2023). This paper reports axon guidance genes contributing to glioma infiltration.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Chokshi, C. R. et al. Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells. Nat. Med. https://doi.org/10.1038/s41591-024-03138-9 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Discovering and targeting vulnerabilities in invasive brain cancer using ROBO1 CAR T cells. Nat Med (2024). https://doi.org/10.1038/s41591-024-03229-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41591-024-03229-7

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer